Ignite Creation Date:
2024-05-05 @ 11:54 AM
Last Modification Date:
2024-10-26 @ 9:15 AM
Study NCT ID:
NCT00166322
Status:
COMPLETED
Last Update Posted:
2008-05-07
First Post:
2005-09-09
Brief Title:
Dopaminergic Neurotransmission in Schizophrenia Patients at Risk and Healthy Subjects
Sponsor:
Ludwig-Maximilians - University of Munich
Organization:
Ludwig-Maximilians - University of Munich
Study Overview
Official Title:
None
Status:
COMPLETED
Status Verified Date:
2008-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study is an investigation of the dopaminergic neurotransmission in patients with schizophrenia patients at risk for the development of schizophrenia and healthy controls using an iodobenzamide-single photon emission computed tomography IBZM-SPECT imaging technique under amphetamine challenge
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| EK07603 | None | None | None |